SEARCH

SEARCH BY CITATION

References

  • Arreaza G. & Deutsch D. G. (1999) Deletion of a proline-rich region and a transmembrane domain in fatty acid amide hydrolase. FEBS Lett. 454, 5760.DOI: 10.1016/s0014-5793(99)00774-7
  • Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J. A., Fernandez-Ruiz J. J. & Di Marzo V. (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological functions. Biochem. Biophys. Res. Commun. 256, 377380.DOI: 10.1006/bbrc.1999.0254
  • Bloom A. S., Edgemond W. S. & Moldvan J. C. (1997) Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes. Neurochem. Res. 22, 563568.
  • Boger D. L., Patterson J. E., Guan X., Cravatt B. F., Lerner R. A. & Gilula N. B. (1998) Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. Proc. Natl Acad. Sci. USA 95, 48104815.DOI: 10.1073/pnas.95.9.4810
  • Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Cadas H., Di Tomaso E. & Piomelli D. (1997) Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 12261242.
  • Calignano A., La Rana G., Giuffrida A. & Piomelli D. (1998) Control of pain initiation by endogenous cannabinoids. Nature 394, 277281.DOI: 10.1038/28393
  • Canoll P. D., Kraemer R., Teng K. K., Marchionni M. A. & Salzer J. L. (1999) GGF/Neuregulin induces a phenotypic reversion of oligodendrocytes. Mol. Cell. Neurosci. 13, 7994.DOI: 10.1006/mcne.1998.0733
  • Casaccia-Bonnefil P., Kong H. & Chao M. V. (1999) Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ. 5, 357364.
  • Chan G. C.-K., Hinds T. R., Impey S. & Storm D. R. (1998) Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol. J. Neurosci. 18, 53225332.
  • Corasaniti M. T., Navarra M., Nisticò S., Rotiroti D., Maccarrone M., Melino G. & Finazzi-Agrò A. (1998) Requirement for membrane lipid peroxidation in HIV-1 gp120-induced neuroblastoma cell death. Biochem. Biophys. Res. Commun. 246, 686689.DOI: 10.1006/bbrc.1998.8687
  • De Petrocellis L., Melck D., Palmisano A., Bisogno T., Laezza C., Bifulco M. & Di Marzo V. (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl Acad. Sci. USA 95, 83758380.DOI: 10.1073/pnas.95.14.8375
  • Derkinderen P., Toutant M., Burgaya F., Le Bert M., Siciliano J. C., De Franciscis V., Gelman M. & Girault J.-A. (1996) Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 273, 17191722.
  • Deutsch D. G., Goligorsky M. S., Schmid P. C., Krebsbach R. J., Schmid H. H. O., Das S. K., Dey S. K., Arreaza G., Thorup C., Stefano G. & Moore L. C. (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100, 15381546.
  • Devane W. A., Hannus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A. & Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 19461949.
  • Di Marzo V., Bisogno T., De Petrocellis L., Melck D. & Martin B. R. (1999a) Cannabimimetic fatty acid derivatives, the anandamide family and other endocannabinoids. Curr. Med. Chem. 6, 721744.
  • Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J. A. & Kunos G. (1999b) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264, 258267.DOI: 10.1046/j.1432-1327.1999.00631.x
  • Di Marzo V. & Deutsch D. G. (1998) Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol. Dis. 5, 386404.DOI: 10.1006/nbdi.1998.0214
  • Di Marzo V., Sepe N., De Petrocellis L., Berger A., Crozier G., Fride E. & Mechoulam R. (1998) Trick or treat from food endocannabinoids? Nature 396, 636.DOI: 10.1038/25267
  • Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S. D. & Leon A. (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl Acad. Sci. USA 92, 33763380.
  • Felder C. C., Nielsen A., Briley E. M., Palkovits M., Priller J., Axelrod J., Nguyen D. N., Richardson J. M., Riggin R. M., Koppel G. A., Paul S. M. & Becker G. W. (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393, 231235.DOI: 10.1016/0014-5793(96)00891-5
  • Fernandez-Ruiz J., Berrendero F., Hernandez M. L. & Ramos J. A. (2000) The endogenous cannabinoid system and brain development. Trends Neurosci. 23, 1420.DOI: 10.1016/s0166-2236(99)01491-5
  • Fontana A., Di Marzo V., Cadas H. & Piomelli D. (1995) Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines. Prostaglandins Leukot. Essent. Fatty Acids 53, 301308.
  • Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G. & Casellas P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 5461.
  • Galve-Roperh I., Sànchez C., Cortes M. L., Del Pulgar T. G., Izquierdo M. & Guzman M. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6, 313316.DOI: 10.1038/73171
  • Giuffrida A. & Piomelli D. (1998) Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett. 422, 373376.DOI: 10.1016/s0014-5793(98)00046-5
  • Giuffrida A., Parsons L. H., Kerr T. M., Rodriguez de Fonseca F., Navarro M. & Piomelli D. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2, 358363.
  • Hampson A. J., Grimaldi M., Axelrod J. & Wink D. (1998) Cannabidiol and (-) delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl Acad. Sci. USA 95, 82688273.DOI: 10.1073/pnas.95.14.8268
  • Hansen H. S., Moesgaard B., Hansen H. H., Schousboe A. & Petersen G. (1999) Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. Lipids 34, S327S330.
  • Kempe K., Hsu F.-F. & Bohrer A. (1996) Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J. Biol. Chem. 271, 1728717295.
  • Lambert D. M. & Di Marzo V. (1999) The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr. Med. Chem. 6, 757773.
  • Maccarrone M., Van Der Stelt M., Rossi A., Veldink G. A., Vliegenthart J. F. G. & Finazzi-Agrò A. (1998) Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem. 273, 3233232339.
  • Maccarrone M., Bari M. & Finazzi-Agrò A. (1999) A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase. Anal. Biochem. 267, 314318.DOI: 10.1006/abio.1998.2964
  • Maccarrone M., Bari M., Lorenzon T., Bisogno T., Di Marzo V. & Finazzi-Agrò A. (2000a) Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem. 275, 1348413492.
  • Maccarrone M., Valensise H., Bari M., Lazzarin N., Romanini C. & Finazzi-Agrò A. (2000b) Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355, 13261329.DOI: 10.1016/s0140-6736(00)02115-2
  • Mechoulam R., Fride E. & Di Marzo V. (1998) Endocannabinoids. Eur. J. Pharmacol. 359, 118.DOI: 10.1016/s0014-2999(98)00649-9
  • Perry T. L., Berry K., Hansen S., Diamond S. & Mok C. (1971) Regional distribution of amino acids in human brain obtained at autopsy. J. Neurochem. 18, 513519.
  • Perry A., Stafford S. L., Scheithauer B. W., Suman V. J. & Lohse C. M. (1997) Meningioma grading: an analysis of histological parameters. Am. J. Surg. Pathol. 21, 14551465.
  • Pertwee R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129180.DOI: 10.1016/s0163-7258(96)00204-5
  • Piomelli D., Beltramo M., Glasnapp S., Lin S. Y., Goutopoulos A., Xie X. Q. & Makriyannis A. (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl Acad. Sci. USA 96, 58025807.DOI: 10.1073/pnas.96.10.5802
  • Randall M. D., Alexander S. P. H., Bennett T., Boyd E. A., Fry J. R., Gardiner S. M., Kemp P. A., McCulloch A. I. & Kendall D. A. (1996) An endogenous cannabinoid as an endothelium derived vasorelaxant. Biochem. Biophys. Res. Commun. 229, 114120.DOI: 10.1006/bbrc.1996.1766
  • Sànchez C., Galve-Roperh I., Canova C., Brachet P. & Guzmàn M. (1998) Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436, 610.DOI: 10.1016/s0014-5793(98)01085-0
  • Schmid P. C., Krebsbach R. J., Perry S. R., Dettmer T. M., Maasson J. L. & Schmid H. H. (1995) Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375, 117120.DOI: 10.1016/0014-5793(95)01194-j
  • Schmid P. C., Paria B. C., Krebsbach R. J., Schmid H. H. O. & Dey S. K. (1997) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. Natl Acad. Sci. USA 94, 41884192.DOI: 10.1073/pnas.94.8.4188
  • Schwarz H., Blanco F. J. & Lotz M. (1994) Anandamide, an endogenous cannabinoid receptor agonist, inhibits lymphocyte proliferation and induces apoptosis. J. Neuroimmunol. 55, 107115.
  • Self D. W. (1999) Anandamide: a candidate neurotransmitter heads for the big leagues. Nat. Neurosci. 2, 303304.
  • Skaper S. D., Buriani A., Dal Toso R., Petrelli L., Romanello S., Facci L. & Leon A. (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl Acad. Sci. USA 93, 39843989.DOI: 10.1073/pnas.93.9.3984
  • Stella N., Schweitzer P. & Piomelli D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773778.DOI: 10.1038/42015
  • Sugiura T., Kodaka T., Nakane S., Kishimoto S., Kondo S. & Waku K. (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243, 838843.DOI: 10.1006/bbrc.1998.8187
  • Di Tomaso E., Beltramo M. & Piomelli D. (1996) Brain cannabinoids in chocolate. Nature 382, 677678.
  • Van der Stelt M., Paoletti A. M., Maccarrone M., Nieuwenhuizen W. F., Bagetta G., Veldink G. A., Finazzi-Agrò A. & Vliegenthart J. F. G. (1997) The effect of dioxygenation of N-linoleoylamides on their cannabinomimetic properties. FEBS Lett. 415, 313316.DOI: 10.1016/s0014-5793(97)01148-4
  • Venance L., Piomelli D., Glowinski J. & Giaume C. (1995) Inhibition by anandamide of gap junctions and innercellular calcium signalling in striatal astrocytes. Nature 376, 590594.
  • Wagner J. A., Varga C., Jàrai Z. & Kunos G. (1999) Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33, 429434.
  • Wagner J. A., Varga K. & Kunos G. (1998) Cardiovascular actions of cannabinoids and their generation during shock. J. Mol. Med. 76, 824836.
  • Yang H.-Y. T., Karoum F., Felder C., Badger H., Wang T.-C. L. & Markey S. P. (1999) GC/MS analysis of anandamide and quantification of N-arachidonoyl-phosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J. Neurochem. 72, 19591968.
  • Zygmunt P. M., Petersson J., Andersson D. A., Chuang H.-H., Sorgård M., Di Marzo V., Julius D. & Högestätt E. D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452457.DOI: 10.1038/22761